← Back
$ANIP All transactions

ANI PHARMACEUTICALS INC

▼ SELL 10b5-1 Plan

$ Value

$538K

Shares

7,032

Price

$77

Filed

Feb 17

Insider

Name

Mutz Christopher

Title

HEAD OF RARE DISEASE

CIK

0001846487

Roles

Officer

Transaction Details

Transaction Date

2026-02-12

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

92,566

Footnotes

Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 6,202 shares of restricted stock, the grant of which was previously reported on February 18, 2025. | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025. | The shares were sold in multiple trades at prices ranging from $75.43 to $76.92. The price reported above reflects the weighted average sales price. | Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,697 shares of restricted stock, the grant of which was previously reported on February 16, 2024.

Filing Info

Accession No.

0001846487-26-000004

Form Type

4

Issuer CIK

0001023024

Mutz Christopher's History

Date Ticker Type Value
2026-03-13 ANIP $227K
2026-03-09 ANIP $267K
2026-03-07 ANIP F $245K
2026-03-06 ANIP $157K
2026-03-02 ANIP $31K
2026-02-28 ANIP F $164K
2026-02-26 ANIP A $1.6M
2026-02-20 ANIP $415K
2026-02-14 ANIP F $186K
2026-02-12 ANIP F $243K

Other Insiders at ANIP (90d)

Insider Bought Sold Last
Rowland Thomas Andrew
SVP, HEAD - ESTABLISHED BRANDS
$357K 2026-03-11
CAREY STEPHEN P.
SVP & CFO
$552K 2026-03-07
Walsh Patrick D $445K 2026-03-03
Lalwani Nikhil
PRESIDENT & CEO
2026-03-07
Gutwerg Ori
SVP, GENERICS
$158K 2026-03-07
Mutz Christopher
HEAD OF RARE DISEASE
$1.1M 2026-03-13
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
2026-02-26
Gassert Chad
SVP - CORP. DEV. & STRATEGY
2026-02-28
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
$114K 2026-04-13
Davis Krista
SVP, CHIEF HR OFFICER
$785K 2026-03-09